A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/03/2011	US20110269818 Modulation of prion expression
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269810 Selective inhibitors of c-jun n-terminal kinase
11/03/2011	US20110269805 Method of treating sensorimotor disorders with 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
11/03/2011	US20110269793 Method for preventing tau protein aggregation and treating alzheimer's disease with a quinoline derivative compound
11/03/2011	US20110269788 Spiro-oxindole-derivatives as sodium channel blockers
11/03/2011	US20110269787 Azabicyclic Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
11/03/2011	US20110269785 Substituted 2-Aminoacetamides and the Use Thereof
11/03/2011	US20110269784 Use of tetrahydropyrimidines
11/03/2011	US20110269783 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/03/2011	US20110269782 Use of nmda activity enhancers to treat hypersomnia, reduced wakefulness or reduced vigilance
11/03/2011	US20110269778 Novel diphenyl purine derivatives useful as modulators of nicotinic acetylcholine receptors
11/03/2011	US20110269777 Methods and compositions for treating schizophrenia using antipsychotic combination therapy
11/03/2011	US20110269775 Piperazine derivatives
11/03/2011	US20110269773 Dihydrofuro pyrimidines as akt protein kinase inhibitors
11/03/2011	US20110269769 Imidazole derivatives useful as inhibitors of faah
11/03/2011	US20110269768 Urotensin ii receptor antagonists
11/03/2011	US20110269764 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of synapse function
11/03/2011	US20110269763 CRTH2 receptor ligands for medicinal uses
11/03/2011	US20110269762 Methods for treating atrial fibrillation and reducing stroke rate in atrial fibrillation patients
11/03/2011	US20110269759 Pyrimidine compounds as delta opioid receptor modulators
11/03/2011	US20110269757 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
11/03/2011	US20110269752 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
11/03/2011	US20110269748 2-aniline-4-aryl substituted thiazole derivatives
11/03/2011	US20110269745 6-ARYLALKYLAMINO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
11/03/2011	US20110269742 Serotonin 5-HT2B Receptor Inhibitors
11/03/2011	US20110269739 Kinase inhibitors
11/03/2011	US20110269738 Compounds
11/03/2011	US20110269733 Silent Desensitizers of Neuronal nAChR and Methods of Use Thereof
11/03/2011	US20110269727 Composition to reduce allodynic back pain and related method of use
11/03/2011	US20110269724 Combination Therapy with Non-Selective COX Inhibitors to Prevent COX-Related Gastric Injuries
11/03/2011	US20110269722 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269717 Neurogenesis by modulating angiotensin
11/03/2011	US20110269713 Bryostatin analogues and methods of making and using thereof
11/03/2011	US20110269709 Prodrugs containing novel bio-cleavable linkers
11/03/2011	US20110269708 P2x7 antagonists to treat affective disorders
11/03/2011	US20110269705 Quinolone compound and pharmaceutical composition
11/03/2011	US20110269689 High penetration compositions and their applications
11/03/2011	US20110269688 Genetic Alterations Associated with Schizophrenia and Methods of Use Thereof for the Diagnosis and Treatment of the Same
11/03/2011	US20110269682 Compositions and Methods for Treatment During Non-Acute Periods Following CNS Neurological Injury
11/03/2011	US20110269681 Prolactin Induced Increase in Neural Stem Cell Numbers
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110269668 Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/03/2011	US20110269666 Method and drug composition for treating septic shock hypotension
11/03/2011	US20110268823 Method for preparing extract fracton reinforced with ginsenosides rg1 or rb1 from ginseng
11/03/2011	US20110268809 Nicotine-Containing Pharmaceutical Compositions
11/03/2011	US20110268808 Dual-release pharmaceutical suspension
11/03/2011	US20110268799 Oral controlled release dosage form
11/03/2011	US20110268798 Orally disntegrating tablets for the treatment of pain
11/03/2011	US20110268796 Pharmaceutical formulations useful in the treatment of insomnia
11/03/2011	US20110268786 Patch production technology
11/03/2011	US20110268785 Propynylaminoindan Transdermal Compositions
11/03/2011	US20110268779 Gum compositions
11/03/2011	US20110268774 preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof
11/03/2011	US20110268765 Injectable Botulinum Toxin Formulations
11/03/2011	US20110268756 Modified amyloid beta peptide
11/03/2011	US20110268748 NURR-1 Interacting Protein (NuIP)
11/03/2011	US20110268747 Stxbp1 as psychiatric biomarker in murine model system and their uses
11/03/2011	US20110268732 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
11/03/2011	US20110268729 Treatment of amyotrophic lateral sclerosis by nogo-a-antagonist
11/03/2011	US20110268725 Anti-NGF antibodies for the treatment of various disorders
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268717 Herbal-Based Compositions for Alleviating Symptoms Associated with Autism
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268706 Preparation method of porous hyaluronic acid sponge for cell delivery system
11/03/2011	US20110268705 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival
11/03/2011	US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	CA2797858A1 Sox9 inhibitors
11/03/2011	CA2796034A1 Nmn modulator
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/03/2011	CA2795218A1 Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
11/03/2011	CA2794824A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
11/03/2011	CA2793859A1 Therapeutic agent and preventative agent for alzheimer's disease
11/02/2011	EP2383271A1 Aminoquinolones as GSK-3 Inhibitors
11/02/2011	EP2383255A1 New compounds, synthesis and use thereof in the treatment of pain
11/02/2011	EP2382984A2 GRF analog compositions and their use
11/02/2011	EP2382982A2 Neural regeneration peptide and methods for their use in treatment of brain damage
11/02/2011	EP2382977A1 Therapeutic agents targeting the ncca-atp channel and methods of use thereof
11/02/2011	EP2382975A2 Neurogenesis by modulating angiotensin
11/02/2011	EP2382974A1 Use of cyclosquaramide compounds as anti-tumour agents
11/02/2011	EP2382972A1 Methods for preventing and treating neurodegenerative disorders
11/02/2011	EP2382872A1 Polar lipid mixtures, their preparation and uses
11/02/2011	EP2382219A1 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
11/02/2011	EP2382213A1 One-step process for preparing paliperidone and its oxalate salt
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2382191A1 Novel benzenesulfonamides as calcium channel blockers
11/02/2011	EP2381955A1 Combination therapies using nap
11/02/2011	EP2381948A2 Compounds and methods for enhancing erythropoiesis
11/02/2011	EP2381941A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
11/02/2011	EP2381940A2 A new family of pain producing substances and methods to produce novel analgesic drugs
11/02/2011	EP2381934A2 Improving cognitive function
11/02/2011	EP2294063B1 Pyrrolidine ether derivatives as nk3 receptor antagonists
11/02/2011	EP2283008B1 Pyrrole derivatives, preparation of same and therapeutic application thereof
11/02/2011	EP2282766B1 Suture line administration technique using botulinum toxins
11/02/2011	EP2203458B1 Cyanoaminoquinolones as gsk-3 inhibitors

1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 1833